Title
Fasinumab word cloud
Description
This is a word cloud about Fasinumab. Fasinumab was an investigational therapy developed by Regeneron and Teva for the treatment of chronic pain particularly in conditions like osteoarthritis (OA) of the knee or hip and chronic low back pain (per Google AI overview).
Type
Category
-
Date
2017
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
![A screenshot of a Formulary update page on the Xartemis™ XR (oxycodone HCI and acetaminophen Extended-Release Tablets (CII)) website. It explains that "Xartemis™ Xu is available unrestricted on Tier 3 for State of Connecticut EMP (CT) Commercial Patients. No PA/step therapy requirement. Patients will have an average co-pay of [placeholder]." The page has a white green and grey background with purple menu bar at the bottom.](https://oida-resources-images.azureedge.net/public/full/2d0e21be-f2dc-4e52-a1df-81df18c3880c.jpeg)
